Back to User profile » Dr Tomomi Kato

Paper published by Dr Tomomi Kato:


Pembrolizumab and salvage chemotherapy in EGFR T790M-positive non-small-cell lung cancer with high PD-L1 expression

Tozuka T, Seike M, Minegishi Y, Kitagawa S, Kato T, Takano N, Hisakane K, Takahashi S, Kobayashi K, Kashiwada T, Sugano T, Takeuchi S, Kunugi S, Noro R, Saito Y, Kubota K, Gemma A

OncoTargets and Therapy 2018, 11:5601-5605

Published Date: 7 September 2018